MYLAN PHARMS INC FDA Approval ANDA 211948

ANDA 211948

MYLAN PHARMS INC

FDA Drug Application

Application #211948

Application Sponsors

ANDA 211948MYLAN PHARMS INC

Marketing Status

None (Tentative Approval)001

Application Products

001TABLET, EXTENDED RELEASE;ORAL82.5MG0PREGABALINPREGABALIN

FDA Submissions

UNKNOWN; ORIG1TA2020-09-11STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAB

CDER Filings

MYLAN PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211948
            [companyName] => MYLAN PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"PREGABALIN","activeIngredients":"PREGABALIN","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/11\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-09-11
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.